170 related articles for article (PubMed ID: 31560972)
1. Mycophenolic acid (MPA) modulates host cellular autophagy progression in sub genomic dengue virus-2 replicon cells.
Manchala NR; Dungdung R; Trivedi P; Unniyampurath U; Pilankatta R
Microb Pathog; 2019 Dec; 137():103762. PubMed ID: 31560972
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
[TBL] [Abstract][Full Text] [Related]
3. Regulation of autophagy, glucose uptake, and glycolysis under dengue virus infection.
Lee YR; Wu SY; Chen RY; Lin YS; Yeh TM; Liu HS
Kaohsiung J Med Sci; 2020 Nov; 36(11):911-919. PubMed ID: 32783363
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus.
Balasubramanian A; Teramoto T; Kulkarni AA; Bhattacharjee AK; Padmanabhan R
Antiviral Res; 2017 Jan; 137():141-150. PubMed ID: 27889529
[TBL] [Abstract][Full Text] [Related]
5. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
6. Dengue Virus Inhibition of Autophagic Flux and Dependency of Viral Replication on Proteasomal Degradation of the Autophagy Receptor p62.
Metz P; Chiramel A; Chatel-Chaix L; Alvisi G; Bankhead P; Mora-Rodriguez R; Long G; Hamacher-Brady A; Brady NR; Bartenschlager R
J Virol; 2015 Aug; 89(15):8026-41. PubMed ID: 26018155
[TBL] [Abstract][Full Text] [Related]
7. Identification of quinolone derivatives as effective anti-Dengue virus agents.
Nobori H; Uemura K; Toba S; Sanaki T; Shishido T; Hall WW; Orba Y; Sawa H; Sato A
Antiviral Res; 2020 Dec; 184():104969. PubMed ID: 33160000
[TBL] [Abstract][Full Text] [Related]
8. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
[TBL] [Abstract][Full Text] [Related]
9. Infection of Aedes albopictus Mosquito C6/36 Cells with the
Teramoto T; Huang X; Armbruster PA; Padmanabhan R
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092581
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dengue virus replication by mycophenolic acid and ribavirin.
Takhampunya R; Ubol S; Houng HS; Cameron CE; Padmanabhan R
J Gen Virol; 2006 Jul; 87(Pt 7):1947-1952. PubMed ID: 16760396
[TBL] [Abstract][Full Text] [Related]
12. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.
Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R
Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954
[TBL] [Abstract][Full Text] [Related]
13. A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease.
Yang CC; Hu HS; Wu RH; Wu SH; Lee SJ; Jiaang WT; Chern JH; Huang ZS; Wu HN; Chang CM; Yueh A
Antimicrob Agents Chemother; 2014; 58(1):110-9. PubMed ID: 24145533
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.
Ng CY; Gu F; Phong WY; Chen YL; Lim SP; Davidson A; Vasudevan SG
Antiviral Res; 2007 Dec; 76(3):222-31. PubMed ID: 17662475
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
[TBL] [Abstract][Full Text] [Related]
16. In-vitro antiviral action of Eupatorium perfoliatum against dengue virus infection: Modulation of mTOR signaling and autophagy.
Sinha M; Chakraborty U; Kool A; Chakravarti M; Das S; Ghosh S; Thakur L; Khuranna A; Nayak D; Basu B; Kar S; Ray R; Das S
J Ethnopharmacol; 2022 Jan; 282():114627. PubMed ID: 34509603
[TBL] [Abstract][Full Text] [Related]
17. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs.
Kato F; Kobayashi T; Tajima S; Takasaki T; Miura T; Igarashi T; Hishiki T
Jpn J Infect Dis; 2014; 67(3):209-12. PubMed ID: 24858611
[TBL] [Abstract][Full Text] [Related]
19. Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication.
Hishiki T; Kato F; Nio Y; Watanabe S; Wen Tan NW; Yamane D; Miyazaki Y; Lin CC; Suzuki R; Tajima S; Lim CK; Saijo M; Hijikata M; Vasudevan SG; Takasaki T
Antiviral Res; 2019 May; 165():42-46. PubMed ID: 30853381
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA.
Diamond MS; Zachariah M; Harris E
Virology; 2002 Dec; 304(2):211-21. PubMed ID: 12504563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
